Related Experiment Videos
Intranasal sufentanil for pre-operative sedation.
M Vercauteren1, E Boeckx, G Hanegreefs
1Department of Anaesthesiology, University Hospital, Antwerp, Belgium.
Anaesthesia
|April 1, 1988
Summary
Nasal sufentanil effectively sedates patients, with 10-20 microgram doses proving optimal. This potent narcotic agent offers rapid-onset sedation with minor side effects, making it a viable premedicant option.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Sufentanil is a potent, short-acting narcotic agent.
- Nasal administration offers a potential alternative route for drug delivery.
Purpose of the Study:
- To evaluate the efficacy and safety of nasal sufentanil as a premedicant.
- To determine optimal dosage and delivery methods (spray vs. drops).
Main Methods:
- A dose-ranging study of nasal sufentanil (5, 10, 20 micrograms).
- Comparison of nasal spray and nose drop formulations.
- A double-blind study comparing sufentanil nose drops to saline placebo.
Main Results:
- Doses of 10 and 20 micrograms of nasal sufentanil were effective for sedation.
- Sedation onset was rapid but of limited duration.
- Minor side effects were observed.
- No significant difference was noted between nasal spray and nose drop delivery.
Conclusions:
- Nasal sufentanil is an effective premedicant, providing rapid sedation.
- Optimal dosage appears to be between 10 and 20 micrograms.
- Further research may explore optimizing duration or combination therapies.